- Home
- Publications
- Publication Search
- Publication Details
Title
Lonafarnib: First Approval
Authors
Keywords
-
Journal
DRUGS
Volume 81, Issue 2, Pages 283-289
Publisher
Springer Science and Business Media LLC
Online
2021-02-19
DOI
10.1007/s40265-020-01464-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Lonafarnib-Like Compounds: Pharmacophore Modeling and Molecular Dynamics Studies
- (2020) Shailima Rampogu et al. ACS Omega
- Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing
- (2020) Solenn M. Guilbert et al. METHODS
- A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study
- (2020) Christopher Koh et al. JOURNAL OF HEPATOLOGY
- Transient introduction of human telomerase mRNA improves hallmarks of progeria cells
- (2019) Yanhui Li et al. AGING CELL
- Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
- (2018) Cihan Yurdaydin et al. HEPATOLOGY
- Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads
- (2018) C. Yurdaydin et al. JOURNAL OF HEPATOLOGY
- An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
- (2018) Karim Harhouri et al. Nucleus
- An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
- (2018) Karim Harhouri et al. Nucleus
- A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
- (2017) C. Koh et al. JOURNAL OF HEPATOLOGY
- Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
- (2017) Diana Gabriel et al. Oncotarget
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- (2015) Christopher Koh et al. LANCET INFECTIOUS DISEASES
- Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome
- (2014) Leslie B. Gordon et al. CIRCULATION
- Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment
- (2013) N. J. Ullrich et al. NEUROLOGY
- Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome
- (2012) L. B. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started